Patent details
EP1876893 Title: CANCER TREATMENT BY COMBINED INHIBITION OF PROTEASOME AND TELOMERASE ACTIVITIES
Basic Information
- Publication number:
- EP1876893
- PCT Application Number:
- PCT/US/2006/014137
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067502278
- PCT Publication Number:
- WO/2006/113470
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CANCER TREATMENT BY COMBINED INHIBITION OF PROTEASOME AND TELOMERASE ACTIVITIES
- French Title of Invention:
- PROCEDE POUR TRAITER UN CANCER GRACE A L'INHIBITION COMBINEE D'ACTIVITES DE PROTEASOME ET DE TELOMERASE
- German Title of Invention:
- BEHANDLUNG VON KREBS DURCH DIE KOMBINIERTE HEMMUNG DER PROTEASOM- UND TELOMERASEAKTIVITÄTEN
- SPC Number:
Dates
- Filing date:
- 14/04/2006
- Grant date:
- 11/04/2012
- EP Publication Date:
- 11/04/2012
- PCT Publication Date:
- 26/10/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/01/2008
- EP B1 Publication Date:
- 11/04/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 14/04/2012
- Expiration date:
- 14/04/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/04/2006
- Name:
- GERON CORPORATION
- Address:
- 230 Constitution Drive, Menlo Park, CA 94025, United States (US)
- Name:
- MEMORIAL SLOAN-KETTERING CANCER CENTER
- Address:
- 1275 York Avenue, New York, NY 10021, United States (US)
Inventor
1
- Name:
- MOORE Malcolm, A., S.
- Address:
- United States (US)
2
- Name:
- CHIN Allison, C.
- Address:
- United States (US)
Priority
- Priority Number:
- 671630 P
- Priority Date:
- 15/04/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C12N 15/113;
| Filing date | Document type | Number of pages |
|---|